Back to search
Skin Diseases, Bacterial
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Skin Diseases, Bacterial trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Skin Diseases, Bacterial trials you may qualify forThe purpose of this study is to evaluate the pharmacokinetics, safety, and efficacy of povorcitinib in adolescent participants with moderate to severe hidradeni…
Rollover study for participants from predetermined, Incyte-sponsored parent clinical trials of povorcitinib.
Background: * Idiopathic CD4+ lymphocytopenia (ICL) is a condition in which there is a decreased level of CD4+ lymphocytes (a type of white blood cell), which…
This is a multinational, randomized, double-blind, placebo-controlled, Phase 2, dose finding study to evaluate the efficacy and safety of different doses of SAR…
Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease p…
Primary purpose of the study is to assess the concentration of bimekizumab in mature human breast milk.
The purpose of the study is to evaluate the safety of long-term therapy of bimekizumab in study participants with moderate to severe hidradenitis suppurativa (H…
A Prospective Clinical Study on the Efficacy and Safety of Bacterial Lysate (OM-85) Combined with Antihistamines in the Treatment of Chronic Spontaneous Urticar…
This study will examine the phototoxicity, a reaction to light that is like exaggerated sunburn, which occurs in people who take medications such as voriconazol…